Blueberries Medical Corp Stock Performance

BBRRF Stock  USD 0.01  0.0004  4.00%   
On a scale of 0 to 100, Blueberries Medical holds a performance score of 1. The firm shows a Beta (market volatility) of -2.1, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Blueberries Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, Blueberries Medical is expected to outperform it. Please check Blueberries Medical's maximum drawdown and the relationship between the semi variance and day typical price , to make a quick decision on whether Blueberries Medical's price patterns will revert.

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Blueberries Medical Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Blueberries Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow306.5 K
Total Cashflows From Investing Activities-48.8 K
Free Cash Flow-1.7 M
  

Blueberries Medical Relative Risk vs. Return Landscape

If you would invest  1.25  in Blueberries Medical Corp on September 19, 2024 and sell it today you would lose (0.21) from holding Blueberries Medical Corp or give up 16.8% of portfolio value over 90 days. Blueberries Medical Corp is currently producing 0.2493% returns and takes up 10.559% volatility of returns over 90 trading days. Put another way, 94% of traded otc stocks are less volatile than Blueberries, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Blueberries Medical is expected to generate 13.34 times more return on investment than the market. However, the company is 13.34 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.02 per unit of risk.

Blueberries Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Blueberries Medical's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Blueberries Medical Corp, and traders can use it to determine the average amount a Blueberries Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0236

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsBBRRF
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 10.56
  actual daily
94
94% of assets are less volatile

Expected Return

 0.25
  actual daily
4
96% of assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Blueberries Medical is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Blueberries Medical by adding it to a well-diversified portfolio.

Blueberries Medical Fundamentals Growth

Blueberries OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Blueberries Medical, and Blueberries Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Blueberries OTC Stock performance.

About Blueberries Medical Performance

By analyzing Blueberries Medical's fundamental ratios, stakeholders can gain valuable insights into Blueberries Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Blueberries Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Blueberries Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products. BLUEBERRIES MEDICAL is traded on OTC Exchange in the United States.

Things to note about Blueberries Medical Corp performance evaluation

Checking the ongoing alerts about Blueberries Medical for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Blueberries Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Blueberries Medical had very high historical volatility over the last 90 days
Blueberries Medical has some characteristics of a very speculative penny stock
Blueberries Medical has a very high chance of going through financial distress in the upcoming years
Blueberries Medical Corp has accumulated 1.57 M in total debt with debt to equity ratio (D/E) of 4.08, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Blueberries Medical Corp has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Blueberries Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Blueberries Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Blueberries Medical Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Blueberries to invest in growth at high rates of return. When we think about Blueberries Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the revenue of 138.75 K. Net Loss for the year was (5.15 M) with loss before overhead, payroll, taxes, and interest of (245.45 K).
Blueberries Medical Corp has accumulated about 467.13 K in cash with (1.68 M) of positive cash flow from operations.
Roughly 69.0% of Blueberries Medical shares are held by company insiders
Evaluating Blueberries Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Blueberries Medical's otc stock performance include:
  • Analyzing Blueberries Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Blueberries Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Blueberries Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Blueberries Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Blueberries Medical's management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Blueberries Medical's otc stock. These opinions can provide insight into Blueberries Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Blueberries Medical's otc stock performance is not an exact science, and many factors can impact Blueberries Medical's otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Blueberries OTC Stock analysis

When running Blueberries Medical's price analysis, check to measure Blueberries Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blueberries Medical is operating at the current time. Most of Blueberries Medical's value examination focuses on studying past and present price action to predict the probability of Blueberries Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blueberries Medical's price. Additionally, you may evaluate how the addition of Blueberries Medical to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.